Y. Piao

发表

Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept

Susan M. Chang, M. Prados, M. Gilbert, 2013, Targeted Oncology.

Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy

J. D. de Groot, A. K. Lucio-Eterovic, Y. Piao, 2009, Clinical Cancer Research.

Targeting intercellular adhesion molecule-1 prolongs survival in mice bearing bevacizumab-resistant glioblastoma

J. D. de Groot, V. Balasubramaniyan, S. Park, 2017, Oncotarget.

Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity

K. Aldape, H. Jiang, R. Alemany, 2009, Cancer Gene Therapy.

Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept

M. Prados, M. Gilbert, M. Mehta, 2011, Clinical Cancer Research.

Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1α levels in gliomas

H. Jiang, T. Liu, J. Fueyo, 2007, Oncogene.

Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.

J. Heymach, J. D. de Groot, A. Zurita, 2012, Neuro-oncology.

Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas

J. Fueyo, C. Gomez-Manzano, Hong Jiang, 2006, Expert review of anticancer therapy.

A novel CRM1‐dependent nuclear export signal in adenoviral E1A protein regulated by phosphorylation

M. Hung, J. Xu, J. Fueyo, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells

R. Verhaak, J. D. de Groot, Emmanuel Martínez-Ledesma, 2018, Oncotarget.

Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.

J. D. de Groot, D. Flynn, S. Park, 2016, Neuro-oncology.

Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models

J. D. de Groot, K. Jeong, S. Park, 2016, Molecular Cancer Therapeutics.

Neutrophils Promote the Malignant Glioma Phenotype through S100A4

G. Fuller, J. D. de Groot, Y. Piao, 2013, Clinical Cancer Research.

Acquired Resistance to Anti-VEGF Therapy in Glioblastoma Is Associated with a Mesenchymal Transition

J. D. de Groot, E. Sulman, Y. Piao, 2013, Clinical Cancer Research.

Depletion of CLK2 sensitizes glioma stem-like cells to PI3K/mTOR and FGFR inhibitors.

R. Verhaak, J. D. de Groot, K. Jeong, 2020, American journal of cancer research.

Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma

T. Lafortune, J. D. de Groot, John de Groot, 2009, Molecular Cancer Therapeutics.

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

G. Fuller, J. D. de Groot, C. Conrad, 2010, Neuro-oncology.

Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma

G. Fuller, J. D. de Groot, Craig J. Thomas, 2016, Oncotarget.

Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis

J. D. de Groot, R. Liu, Zhimin Lu, 2017, Nature Communications.

Expression of the Receptor Tyrosine Kinase Tie2 in Neoplastic Glial Cells Is Associated with Integrin β1-Dependent Adhesion to the Extracellular Matrix

K. Aldape, G. Fuller, T. Liu, 2006, Molecular Cancer Research.

Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis

J. D. de Groot, Zhimin Lu, Qianming Chen, 2017, Nature Communications.

EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

Tina N. Davis, Forrest M Kievit, Atique U. Ahmed, 2013 .

ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo.

F. Lang, R. Alemany, M. Cascalló, 2007, Cancer research.

Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo

H. Jiang, R. Alemany, W. Yung, 2007, Cancer Gene Therapy.

AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.

J. D. de Groot, Y. Piao, Li Lu, 2009, Neuro-oncology.

Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation

W. Yung, G. Fuller, Y. Piao, 2008, Journal of Neuro-Oncology.

Modulating Antiangiogenic Resistance by Inhibiting the Signal Transducer and Activator of Transcription 3 Pathway in Glioblastoma

G. Fuller, J. D. de Groot, A. Heimberger, 2012, Oncotarget.

Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy

J. D. de Groot, Y. Piao, N. Tiao, 2015, Oncotarget.